CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with HER2-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma who have progressed on or after a trastuzumab-containing regim...
Phase 3
Budapest, Hungary and 157 other locations
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Budapest, Hungary and 197 other locations
and placebo in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).This study aims to explore whether blockade of Transforming Gr...
Phase 3
Budapest, Hungary and 113 other locations
first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Budapest, Hungary and 212 other locations
cancer in the pancreas.Adult participants with metastatic pancreatic adenocarcinoma will receive Test Product (TP) and Reference Product (RP...
Phase 1
Budapest, Hungary and 35 other locations
GEJ adenocarcinoma in adult participants.The primary hypotheses of this study are that pembrolizumab plus chemotherapy is superior to place...
Phase 3
Budapest, Hungary and 214 other locations
The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...
Phase 3
Budapest, Hungary and 199 other locations
Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...
Phase 3
Budapest, Hungary and 148 other locations
The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...
Phase 3
Budapest, Hungary and 342 other locations
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Phase 1, Phase 2
Budapest, Hungary and 110 other locations
Clinical trials
Research sites
Resources
Legal